Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04576247 · ClinicalTrials.gov registry record · NA
Combined Modality Exercise and Appetite in Breast Cancer Survivors
A NA study, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT04576247: Clinical Trial NA study, sponsored by University of Colorado, Denver.
NCT04576247 is a NA study that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04576247, a NA study, was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The overall aim of this research is to assess the feasibility of a 12-week combined aerobic exercise (AEx) and resistance exercise (REx) intervention and elucidate the impact of AEx/REx on several physiological and behavioral components of energy balance among breast cancer survivors (BCS).
Primary Outcome
Number of individuals approached, meeting inclusion criteria, reasons for exclusion, and enrolled in the study
Interventions
- BEHAVIORAL Combined aerobic and resistance exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2020-06-05 |
| Est. Completion | 2021-09-20 |
| Phase | NA |
Why NCT04576247 stopped before completion
NCT04576247 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Combined aerobic and resistance exercise is the first listed.
NCT04576247 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04576247 about?
NCT04576247 is a clinical study titled "Combined Modality Exercise and Appetite in Breast Cancer Survivors". The overall aim of this research is to assess the feasibility of a 12-week combined aerobic exercise (AEx) and resistance exercise (REx) intervention and elucidate the impact of AEx/REx on several physiological and behavioral components of energy balance among breast cancer survivors (BCS).
What is the current status of trial NCT04576247?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2020-06-05. Estimated completion is 2021-09-20.
What interventions are being tested in trial NCT04576247?
The interventions under investigation include: Combined aerobic and resistance exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT04576247?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04576247's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI